Tumor cells fail to trans-induce telomerase in human umbilical vein endothelial cell cultures

Esterina Pascale, Graziella Cimino Reale, Ettore D'Ambrosio

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The shortening of the telomeres that occurs in most somatic cells and untransformed cell cultures is considered a hallmark of cellular senescence. Re-activation of telomerase, which is usually present in immortal cells, avoids telomere shortening and considerably extends the culture life span. Normal human endothelial cells are characterized by an accelerated rate of telomere shortening and reach replicative senescence after a limited number of cell divisions. It has recently been reported that human telomerase reverse transcriptase expression may be strongly up-regulated in human endothelial cells cocultivated with tumor cells. Due to the important implications of this finding on tumor progression, we have extensively analyzed for the presence of telomerase in primary human endothelial cells either cocultivated with tumor cells or grown with tumorconditioned medium. We found modest, but readily detectable, amounts of telomerase in all human endothelial cell cultures analyzed that disappeared as the cultures approached senescence. Quantitative reverse transcription-PCR also showed a direct correlation between human telomerase reverse transcriptase expression and the proliferative index of the cultures. Nevertheless, we did not find any evidence of induction of telomerase activity by tumor cells in any of the tested conditions. All data indicate that telomerase in human endothelial cells follows an activation program that is strictly associated to the culture growth rate.

Original languageEnglish
Pages (from-to)7702-7705
Number of pages4
JournalCancer Research
Volume64
Issue number21
DOIs
Publication statusPublished - Nov 1 2004

Fingerprint

Telomerase
Human Umbilical Vein Endothelial Cells
Telomere Shortening
Endothelial Cells
Cell Culture Techniques
Cell Aging
Neoplasms
Cell Division
Reverse Transcription
Polymerase Chain Reaction
Growth
human TERT protein

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumor cells fail to trans-induce telomerase in human umbilical vein endothelial cell cultures. / Pascale, Esterina; Reale, Graziella Cimino; D'Ambrosio, Ettore.

In: Cancer Research, Vol. 64, No. 21, 01.11.2004, p. 7702-7705.

Research output: Contribution to journalArticle

Pascale, Esterina ; Reale, Graziella Cimino ; D'Ambrosio, Ettore. / Tumor cells fail to trans-induce telomerase in human umbilical vein endothelial cell cultures. In: Cancer Research. 2004 ; Vol. 64, No. 21. pp. 7702-7705.
@article{fb20b8fd45f241678f8ca6efb858f71e,
title = "Tumor cells fail to trans-induce telomerase in human umbilical vein endothelial cell cultures",
abstract = "The shortening of the telomeres that occurs in most somatic cells and untransformed cell cultures is considered a hallmark of cellular senescence. Re-activation of telomerase, which is usually present in immortal cells, avoids telomere shortening and considerably extends the culture life span. Normal human endothelial cells are characterized by an accelerated rate of telomere shortening and reach replicative senescence after a limited number of cell divisions. It has recently been reported that human telomerase reverse transcriptase expression may be strongly up-regulated in human endothelial cells cocultivated with tumor cells. Due to the important implications of this finding on tumor progression, we have extensively analyzed for the presence of telomerase in primary human endothelial cells either cocultivated with tumor cells or grown with tumorconditioned medium. We found modest, but readily detectable, amounts of telomerase in all human endothelial cell cultures analyzed that disappeared as the cultures approached senescence. Quantitative reverse transcription-PCR also showed a direct correlation between human telomerase reverse transcriptase expression and the proliferative index of the cultures. Nevertheless, we did not find any evidence of induction of telomerase activity by tumor cells in any of the tested conditions. All data indicate that telomerase in human endothelial cells follows an activation program that is strictly associated to the culture growth rate.",
author = "Esterina Pascale and Reale, {Graziella Cimino} and Ettore D'Ambrosio",
year = "2004",
month = "11",
day = "1",
doi = "10.1158/0008-5472.CAN-04-1711",
language = "English",
volume = "64",
pages = "7702--7705",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

TY - JOUR

T1 - Tumor cells fail to trans-induce telomerase in human umbilical vein endothelial cell cultures

AU - Pascale, Esterina

AU - Reale, Graziella Cimino

AU - D'Ambrosio, Ettore

PY - 2004/11/1

Y1 - 2004/11/1

N2 - The shortening of the telomeres that occurs in most somatic cells and untransformed cell cultures is considered a hallmark of cellular senescence. Re-activation of telomerase, which is usually present in immortal cells, avoids telomere shortening and considerably extends the culture life span. Normal human endothelial cells are characterized by an accelerated rate of telomere shortening and reach replicative senescence after a limited number of cell divisions. It has recently been reported that human telomerase reverse transcriptase expression may be strongly up-regulated in human endothelial cells cocultivated with tumor cells. Due to the important implications of this finding on tumor progression, we have extensively analyzed for the presence of telomerase in primary human endothelial cells either cocultivated with tumor cells or grown with tumorconditioned medium. We found modest, but readily detectable, amounts of telomerase in all human endothelial cell cultures analyzed that disappeared as the cultures approached senescence. Quantitative reverse transcription-PCR also showed a direct correlation between human telomerase reverse transcriptase expression and the proliferative index of the cultures. Nevertheless, we did not find any evidence of induction of telomerase activity by tumor cells in any of the tested conditions. All data indicate that telomerase in human endothelial cells follows an activation program that is strictly associated to the culture growth rate.

AB - The shortening of the telomeres that occurs in most somatic cells and untransformed cell cultures is considered a hallmark of cellular senescence. Re-activation of telomerase, which is usually present in immortal cells, avoids telomere shortening and considerably extends the culture life span. Normal human endothelial cells are characterized by an accelerated rate of telomere shortening and reach replicative senescence after a limited number of cell divisions. It has recently been reported that human telomerase reverse transcriptase expression may be strongly up-regulated in human endothelial cells cocultivated with tumor cells. Due to the important implications of this finding on tumor progression, we have extensively analyzed for the presence of telomerase in primary human endothelial cells either cocultivated with tumor cells or grown with tumorconditioned medium. We found modest, but readily detectable, amounts of telomerase in all human endothelial cell cultures analyzed that disappeared as the cultures approached senescence. Quantitative reverse transcription-PCR also showed a direct correlation between human telomerase reverse transcriptase expression and the proliferative index of the cultures. Nevertheless, we did not find any evidence of induction of telomerase activity by tumor cells in any of the tested conditions. All data indicate that telomerase in human endothelial cells follows an activation program that is strictly associated to the culture growth rate.

UR - http://www.scopus.com/inward/record.url?scp=7444220144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444220144&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-1711

DO - 10.1158/0008-5472.CAN-04-1711

M3 - Article

VL - 64

SP - 7702

EP - 7705

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 21

ER -